SCIENTURE HOLDINGS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
SCIENTURE HOLDINGS, INC. (SCNX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$6.65 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-07-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2019-07-26
- SCIENTURE HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-06-30 was -$36.42K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-03-31 was $29.77K, a 73.47% increase year-over-year.
- SCIENTURE HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-06-30 was -$13.68K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-03-31 was $17.16K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was -$18.79K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was -$293.52K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|
| 2019-06-30 | -$36.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | -$6.65K 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $29.77K 10-Q · filed 2019-05-13 | ||
| 2018-12-31 | -$18.79K 10-K · filed 2019-03-22 | ||
| 2018-06-30 | -$13.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $3.48K 10-Q · filed 2019-07-26 | |
| 2018-03-31 | $17.16K 10-Q · filed 2019-05-13 | ||
| 2017-12-31 | -$293.52K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |